| http://www.w3.org/ns/prov#value | - The National Multiple Sclerosis Society has issued a practice directive recommending the use of these medications by all patients with clinically significant, relapsing MS. Other therapies directed against MS include the treatment of the MS patient with a (monoclonal) antibody directed against a cytokine, such as TNF-??, IL-6 or IL-12, However, although few would disagree that using these cytokine
|
